Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 65.00
-1.00 (-1.52%)
Oct 26, 2026, 3:30 PM JST
Ribomic Market Cap
Ribomic has a market cap or net worth of 3.68 billion as of October 26, 2026. It is the 35,704th most valuable company in the world and the 3,320th biggest in Japan. Its market cap has decreased by 10.40% in one year.
Market Cap
3.68B
Enterprise Value
895.21M
Revenue
7.50M
Global Rank
Country Rank
#3,320 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 3.68B, a decrease of -84.00%. That is a compound annual growth rate of -14.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 3.68B | -10.76% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.63B |
| BrightPath Biotherapeutics | 5.56B |
| Kringle Pharma | 5.00B |
| PRISM BioLab Co.,LTD | 4.95B |
| Kohjin Bio | 4.03B |
| Chordia Therapeutics | 3.86B |
| Noile-Immune Biotech | 3.78B |
| Transgenic Group | 3.63B |